Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-February 19, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that
View HTML
Toggle Summary Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves
Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves Plainsboro, New Jersey, February 5, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received the CE mark for the NeuraGenT Nerve Guide, an
View HTML
Toggle Summary Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc.
Integra NeuroSciences Awarded Neurosurgery Agreement By Premier, Inc. Neurosurgical Products Offered at Substantial Savings Plainsboro, NJ / January 2, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported that it has been selected as a national supplier for Premier's
View HTML
Toggle Summary Integra LifeSciences Reports Record Revenues of $30.2 Million
Integra LifeSciences Reports Record Revenues of $30.2 Million Please click here for news release.
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Padgett Instruments, Inc.
Integra LifeSciences Announces Acquisition of Padgett Instruments, Inc. Plainsboro, NJ / October 22, 2002 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has acquired Padgett Instruments, Inc., a marketer of instruments used in reconstructive and plastic
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited
Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited Plainsboro, NJ / September 23, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has acquired certain assets, including the
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures
Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Plainsboro, New Jersey, September 24, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing the Helitene®
View HTML
Toggle Summary Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets
Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has launched the Camino® Single
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors
Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors Plainsboro, NJ / September 18, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that effective October 31, 2002 it will increase the size of its Board of Directors to six and
View HTML
Toggle Summary Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents
Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.
View HTML
Toggle Summary Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business
Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million
Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $26.4 million and net income of $0.14 per share for the
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants
Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants PLAINSBORO, N.J. and Pembroke, Mass., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar
Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar PLAINSBORO, N.J.-July 29, 2002-- Integra LifeSciences Holdings
View HTML